Economic Analysis of the CADScor System for Ruling Out Coronary Artery Disease in England View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-08-30

AUTHORS

Mehdi Javanbakht, Atefeh Mashayekhi, Mohsen Rezaei Hemami‬, Michael Branagan-Harris, Eoin Moloney

ABSTRACT

BackgroundCoronary artery disease (CAD) is the most common type of heart and circulatory disease and is the leading cause of death worldwide. The current diagnostic pathway can lead to patient complications and is also extremely costly. A new medical device, the CADScor System (Acarix AB), was developed for the acoustic detection of CAD before patients undergo invasive diagnostic procedures.ObjectivesOur objective was to assess the cost utility of the CADScor System for the diagnosis of CAD at an early stage in the diagnostic testing pathway in England.MethodsA two-part economic model, consisting of a decision tree and Markov model, was developed to consider the cost utility (cost per quality-adjusted life-year [QALY] gained) of introducing the CADScor System for the diagnosis of CAD. The decision tree component explored the short-term costs and diagnostic outcomes associated with introduction of the test compared with the existing testing pathway. A Markov model was developed to explore the longer-term health and economic implications of the condition and original diagnosis, with costs and health effects estimated over different time horizons. Parameter uncertainty was explored in deterministic and probabilistic sensitivity analyses.ResultsBase-case results indicated that the CADScor System would result in cost savings (− £131 per patient) and a marginal increase in QALYs (0.00001) over a 1-year time horizon. Probabilistic results indicated that the intervention had a > 99% probability of being cost effective at a willingness-to-pay threshold of £20,000 per QALY gained and 100% probability of being cost saving. Results from the deterministic sensitivity analyses indicated that variations in parameters related to the accuracy and cost of the CADScor System, and the prevalence of CAD, had the greatest impact on the overall results. The overall cost saving was estimated to be over £12.3 million per 100,000 eligible patient population.ConclusionsThe CADScor System is a potentially cost-saving test for the diagnosis of CAD. When initiated before the use of non-invasive cardiac imaging tests such as computed tomography coronary angiography, the test reduced costs to the healthcare service over various time horizons. More... »

PAGES

1-13

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s41669-021-00297-0

DOI

http://dx.doi.org/10.1007/s41669-021-00297-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1140743852

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34460080


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/09", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Engineering", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0903", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biomedical Engineering", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Device Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Southampton, UK", 
          "id": "http://www.grid.ac/institutes/grid.5491.9", 
          "name": [
            "Optimax Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, SO16 7NS, Southampton, UK", 
            "Device Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Southampton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Javanbakht", 
        "givenName": "Mehdi", 
        "id": "sg:person.01105552644.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105552644.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Optimax Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, SO16 7NS, Southampton, UK", 
          "id": "http://www.grid.ac/institutes/grid.5491.9", 
          "name": [
            "Optimax Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, SO16 7NS, Southampton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mashayekhi", 
        "givenName": "Atefeh", 
        "id": "sg:person.0634117476.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634117476.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Aberdeen, Aberdeen, UK", 
          "id": "http://www.grid.ac/institutes/grid.7107.1", 
          "name": [
            "University of Aberdeen, Aberdeen, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hemami\u202c", 
        "givenName": "Mohsen Rezaei", 
        "id": "sg:person.01114255377.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114255377.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Device Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Southampton, UK", 
          "id": "http://www.grid.ac/institutes/grid.5491.9", 
          "name": [
            "Device Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Southampton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Branagan-Harris", 
        "givenName": "Michael", 
        "id": "sg:person.012635241033.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012635241033.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Optimax Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, SO16 7NS, Southampton, UK", 
          "id": "http://www.grid.ac/institutes/grid.5491.9", 
          "name": [
            "Optimax Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, SO16 7NS, Southampton, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moloney", 
        "givenName": "Eoin", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-3-030-42443-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1127695311", 
          "https://doi.org/10.1007/978-3-030-42443-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10554-015-0753-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023517869", 
          "https://doi.org/10.1007/s10554-015-0753-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10198-019-01096-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1120306126", 
          "https://doi.org/10.1007/s10198-019-01096-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10554-019-01662-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1117764599", 
          "https://doi.org/10.1007/s10554-019-01662-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-08-30", 
    "datePublishedReg": "2021-08-30", 
    "description": "BackgroundCoronary artery disease (CAD) is the most common type of heart and circulatory disease and is the leading cause of death worldwide. The current diagnostic pathway can lead to patient complications and is also extremely costly. A new medical device, the CADScor System (Acarix AB), was developed for the acoustic detection of CAD before patients undergo invasive diagnostic procedures.ObjectivesOur objective was to assess the cost utility of the CADScor System for the diagnosis of CAD at an early stage in the diagnostic testing pathway in England.MethodsA two-part economic model, consisting of a decision tree and Markov model, was developed to consider the cost utility (cost per quality-adjusted life-year [QALY] gained) of introducing the CADScor System for the diagnosis of CAD. The decision tree component explored the short-term costs and diagnostic outcomes associated with introduction of the test compared with the existing testing pathway. A Markov model was developed to explore the longer-term health and economic implications of the condition and original diagnosis, with costs and health effects estimated over different time horizons. Parameter uncertainty was explored in deterministic and probabilistic sensitivity analyses.ResultsBase-case results indicated that the CADScor System would result in cost savings (\u2212\u00a0\u00a3131 per patient) and a marginal increase in QALYs (0.00001) over a 1-year time horizon. Probabilistic results indicated that the intervention had a >\u00a099% probability of being cost effective at a willingness-to-pay threshold of \u00a320,000 per QALY gained and 100% probability of being cost saving. Results from the deterministic sensitivity analyses indicated that variations in parameters related to the accuracy and cost of the CADScor System, and the prevalence of CAD, had the greatest impact on the overall results. The overall cost saving was estimated to be over \u00a312.3 million per 100,000 eligible patient population.ConclusionsThe CADScor System is a potentially cost-saving test for the diagnosis of CAD. When initiated before the use of non-invasive cardiac imaging tests such as computed tomography coronary angiography, the test reduced costs to the healthcare service over various time horizons.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s41669-021-00297-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1284515", 
        "issn": [
          "2509-4262", 
          "2509-4254"
        ], 
        "name": "PharmacoEconomics - Open", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "diagnosis of CAD", 
      "artery disease", 
      "cost utility", 
      "current diagnostic pathway", 
      "ResultsBase-case results", 
      "prevalence of CAD", 
      "BackgroundCoronary artery disease", 
      "cardiac imaging tests", 
      "tomography coronary angiography", 
      "coronary artery disease", 
      "testing pathway", 
      "invasive diagnostic procedures", 
      "cause of death", 
      "eligible patient population", 
      "probabilistic sensitivity analyses", 
      "deterministic sensitivity analyses", 
      "long-term health", 
      "coronary angiography", 
      "patient population", 
      "patient complications", 
      "diagnostic pathway", 
      "circulatory diseases", 
      "imaging tests", 
      "original diagnosis", 
      "overall cost savings", 
      "diagnostic procedures", 
      "cost savings", 
      "diagnosis", 
      "health effects", 
      "diagnostic outcomes", 
      "ObjectivesOur objective", 
      "disease", 
      "healthcare services", 
      "common type", 
      "new medical devices", 
      "time horizon", 
      "pathway", 
      "early stages", 
      "complications", 
      "patients", 
      "angiography", 
      "QALY", 
      "prevalence", 
      "short-term costs", 
      "QALYs", 
      "death", 
      "CAD", 
      "different time horizons", 
      "test", 
      "outcomes", 
      "intervention", 
      "marginal increase", 
      "heart", 
      "cause", 
      "health", 
      "sensitivity analysis", 
      "overall results", 
      "economic model", 
      "economic analysis", 
      "economic implications", 
      "utility", 
      "medical devices", 
      "population", 
      "analysis", 
      "results", 
      "great impact", 
      "Markov model", 
      "increase", 
      "cost", 
      "savings", 
      "effect", 
      "procedure", 
      "England", 
      "objective", 
      "horizon", 
      "use", 
      "stage", 
      "threshold", 
      "detection", 
      "willingness", 
      "parameter uncertainties", 
      "services", 
      "types", 
      "model", 
      "impact", 
      "probabilistic results", 
      "implications", 
      "probability", 
      "system", 
      "introduction", 
      "uncertainty", 
      "components", 
      "conditions", 
      "decision tree", 
      "parameters", 
      "variation", 
      "accuracy", 
      "devices", 
      "trees", 
      "acoustic detection", 
      "tree components", 
      "CADScor System", 
      "diagnostic testing pathway", 
      "two-part economic model", 
      "decision tree component", 
      "ConclusionsThe CADScor System", 
      "cost-saving test", 
      "non-invasive cardiac imaging tests"
    ], 
    "name": "Economic Analysis of the CADScor System for Ruling Out Coronary Artery Disease in England", 
    "pagination": "1-13", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1140743852"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s41669-021-00297-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34460080"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s41669-021-00297-0", 
      "https://app.dimensions.ai/details/publication/pub.1140743852"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_898.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s41669-021-00297-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00297-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00297-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00297-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00297-0'


 

This table displays all metadata directly associated to this object as RDF triples.

220 TRIPLES      22 PREDICATES      138 URIs      124 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s41669-021-00297-0 schema:about anzsrc-for:09
2 anzsrc-for:0903
3 anzsrc-for:14
4 anzsrc-for:1402
5 schema:author N64894e2c46cd499ba9681850bfb7bd94
6 schema:citation sg:pub.10.1007/978-3-030-42443-5
7 sg:pub.10.1007/s10198-019-01096-5
8 sg:pub.10.1007/s10554-015-0753-4
9 sg:pub.10.1007/s10554-019-01662-1
10 schema:datePublished 2021-08-30
11 schema:datePublishedReg 2021-08-30
12 schema:description BackgroundCoronary artery disease (CAD) is the most common type of heart and circulatory disease and is the leading cause of death worldwide. The current diagnostic pathway can lead to patient complications and is also extremely costly. A new medical device, the CADScor System (Acarix AB), was developed for the acoustic detection of CAD before patients undergo invasive diagnostic procedures.ObjectivesOur objective was to assess the cost utility of the CADScor System for the diagnosis of CAD at an early stage in the diagnostic testing pathway in England.MethodsA two-part economic model, consisting of a decision tree and Markov model, was developed to consider the cost utility (cost per quality-adjusted life-year [QALY] gained) of introducing the CADScor System for the diagnosis of CAD. The decision tree component explored the short-term costs and diagnostic outcomes associated with introduction of the test compared with the existing testing pathway. A Markov model was developed to explore the longer-term health and economic implications of the condition and original diagnosis, with costs and health effects estimated over different time horizons. Parameter uncertainty was explored in deterministic and probabilistic sensitivity analyses.ResultsBase-case results indicated that the CADScor System would result in cost savings (− £131 per patient) and a marginal increase in QALYs (0.00001) over a 1-year time horizon. Probabilistic results indicated that the intervention had a > 99% probability of being cost effective at a willingness-to-pay threshold of £20,000 per QALY gained and 100% probability of being cost saving. Results from the deterministic sensitivity analyses indicated that variations in parameters related to the accuracy and cost of the CADScor System, and the prevalence of CAD, had the greatest impact on the overall results. The overall cost saving was estimated to be over £12.3 million per 100,000 eligible patient population.ConclusionsThe CADScor System is a potentially cost-saving test for the diagnosis of CAD. When initiated before the use of non-invasive cardiac imaging tests such as computed tomography coronary angiography, the test reduced costs to the healthcare service over various time horizons.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree true
16 schema:isPartOf sg:journal.1284515
17 schema:keywords BackgroundCoronary artery disease
18 CAD
19 CADScor System
20 ConclusionsThe CADScor System
21 England
22 Markov model
23 ObjectivesOur objective
24 QALY
25 QALYs
26 ResultsBase-case results
27 accuracy
28 acoustic detection
29 analysis
30 angiography
31 artery disease
32 cardiac imaging tests
33 cause
34 cause of death
35 circulatory diseases
36 common type
37 complications
38 components
39 conditions
40 coronary angiography
41 coronary artery disease
42 cost
43 cost savings
44 cost utility
45 cost-saving test
46 current diagnostic pathway
47 death
48 decision tree
49 decision tree component
50 detection
51 deterministic sensitivity analyses
52 devices
53 diagnosis
54 diagnosis of CAD
55 diagnostic outcomes
56 diagnostic pathway
57 diagnostic procedures
58 diagnostic testing pathway
59 different time horizons
60 disease
61 early stages
62 economic analysis
63 economic implications
64 economic model
65 effect
66 eligible patient population
67 great impact
68 health
69 health effects
70 healthcare services
71 heart
72 horizon
73 imaging tests
74 impact
75 implications
76 increase
77 intervention
78 introduction
79 invasive diagnostic procedures
80 long-term health
81 marginal increase
82 medical devices
83 model
84 new medical devices
85 non-invasive cardiac imaging tests
86 objective
87 original diagnosis
88 outcomes
89 overall cost savings
90 overall results
91 parameter uncertainties
92 parameters
93 pathway
94 patient complications
95 patient population
96 patients
97 population
98 prevalence
99 prevalence of CAD
100 probabilistic results
101 probabilistic sensitivity analyses
102 probability
103 procedure
104 results
105 savings
106 sensitivity analysis
107 services
108 short-term costs
109 stage
110 system
111 test
112 testing pathway
113 threshold
114 time horizon
115 tomography coronary angiography
116 tree components
117 trees
118 two-part economic model
119 types
120 uncertainty
121 use
122 utility
123 variation
124 willingness
125 schema:name Economic Analysis of the CADScor System for Ruling Out Coronary Artery Disease in England
126 schema:pagination 1-13
127 schema:productId N072012b374694b53bc13462329cd7ef3
128 N12963ed59a84493eb11794dd8e020ce9
129 Nb6a5b21145064362b63bc821dc601446
130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1140743852
131 https://doi.org/10.1007/s41669-021-00297-0
132 schema:sdDatePublished 2022-01-01T18:59
133 schema:sdLicense https://scigraph.springernature.com/explorer/license/
134 schema:sdPublisher N467207eec6874428a4c9efb5b884b827
135 schema:url https://doi.org/10.1007/s41669-021-00297-0
136 sgo:license sg:explorer/license/
137 sgo:sdDataset articles
138 rdf:type schema:ScholarlyArticle
139 N072012b374694b53bc13462329cd7ef3 schema:name dimensions_id
140 schema:value pub.1140743852
141 rdf:type schema:PropertyValue
142 N12963ed59a84493eb11794dd8e020ce9 schema:name pubmed_id
143 schema:value 34460080
144 rdf:type schema:PropertyValue
145 N20166ec6c0f84cc5a263c25a1bea7273 rdf:first sg:person.012635241033.88
146 rdf:rest N6f1b7d9de1e347d598f601d2b9e08f99
147 N467207eec6874428a4c9efb5b884b827 schema:name Springer Nature - SN SciGraph project
148 rdf:type schema:Organization
149 N64894e2c46cd499ba9681850bfb7bd94 rdf:first sg:person.01105552644.92
150 rdf:rest Nd09d039026a14bff99296f58c9729dc2
151 N6f1b7d9de1e347d598f601d2b9e08f99 rdf:first Na9820833dfb34d329ca442ea221e7b76
152 rdf:rest rdf:nil
153 N785523bcb163451fb18bc817e0642b6f rdf:first sg:person.01114255377.35
154 rdf:rest N20166ec6c0f84cc5a263c25a1bea7273
155 Na9820833dfb34d329ca442ea221e7b76 schema:affiliation grid-institutes:grid.5491.9
156 schema:familyName Moloney
157 schema:givenName Eoin
158 rdf:type schema:Person
159 Nb6a5b21145064362b63bc821dc601446 schema:name doi
160 schema:value 10.1007/s41669-021-00297-0
161 rdf:type schema:PropertyValue
162 Nd09d039026a14bff99296f58c9729dc2 rdf:first sg:person.0634117476.41
163 rdf:rest N785523bcb163451fb18bc817e0642b6f
164 anzsrc-for:09 schema:inDefinedTermSet anzsrc-for:
165 schema:name Engineering
166 rdf:type schema:DefinedTerm
167 anzsrc-for:0903 schema:inDefinedTermSet anzsrc-for:
168 schema:name Biomedical Engineering
169 rdf:type schema:DefinedTerm
170 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
171 schema:name Economics
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
174 schema:name Applied Economics
175 rdf:type schema:DefinedTerm
176 sg:journal.1284515 schema:issn 2509-4254
177 2509-4262
178 schema:name PharmacoEconomics - Open
179 schema:publisher Springer Nature
180 rdf:type schema:Periodical
181 sg:person.01105552644.92 schema:affiliation grid-institutes:grid.5491.9
182 schema:familyName Javanbakht
183 schema:givenName Mehdi
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105552644.92
185 rdf:type schema:Person
186 sg:person.01114255377.35 schema:affiliation grid-institutes:grid.7107.1
187 schema:familyName Hemami‬
188 schema:givenName Mohsen Rezaei
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114255377.35
190 rdf:type schema:Person
191 sg:person.012635241033.88 schema:affiliation grid-institutes:grid.5491.9
192 schema:familyName Branagan-Harris
193 schema:givenName Michael
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012635241033.88
195 rdf:type schema:Person
196 sg:person.0634117476.41 schema:affiliation grid-institutes:grid.5491.9
197 schema:familyName Mashayekhi
198 schema:givenName Atefeh
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634117476.41
200 rdf:type schema:Person
201 sg:pub.10.1007/978-3-030-42443-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1127695311
202 https://doi.org/10.1007/978-3-030-42443-5
203 rdf:type schema:CreativeWork
204 sg:pub.10.1007/s10198-019-01096-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1120306126
205 https://doi.org/10.1007/s10198-019-01096-5
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/s10554-015-0753-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023517869
208 https://doi.org/10.1007/s10554-015-0753-4
209 rdf:type schema:CreativeWork
210 sg:pub.10.1007/s10554-019-01662-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1117764599
211 https://doi.org/10.1007/s10554-019-01662-1
212 rdf:type schema:CreativeWork
213 grid-institutes:grid.5491.9 schema:alternateName Device Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Southampton, UK
214 Optimax Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, SO16 7NS, Southampton, UK
215 schema:name Device Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Southampton, UK
216 Optimax Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, SO16 7NS, Southampton, UK
217 rdf:type schema:Organization
218 grid-institutes:grid.7107.1 schema:alternateName University of Aberdeen, Aberdeen, UK
219 schema:name University of Aberdeen, Aberdeen, UK
220 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...